Key Points Chief Medical Officer Harold Bernstein sold 9,705 shares for ~$255,000 on September 4, 2026. The transaction involved shares equal to 100% of the insider's directly held common stock before the filing. The sale occurred as the company's shares lost about half their value in recent months. 10 stocks we like better than Maze Therapeutics › Harold Bernstein, President of Research and Development and Chief Medical Officer at Maze Therapeutics, Inc. (NASDAQ:MAZE) , sold 9,705 shares of common stock on September 4, 2026, according to an SEC Form 4 filing . Transaction summary Transaction value based on SEC Form 4 weighted average sale price ($26.22). Key questions What was the nature of this transaction?
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.